COLLINA AFRIYIE: Open Payments
NPI 1316336449 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,045 in 114 payments from 26 companies in 2025. Trend: 2023 $2,091 · 2024 $1,985 · 2025 $2,045
Food & beverage: $2,030Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $449 |
| Lilly USA, LLC | 13 | $208 |
| Eisai Inc. | 6 | $191 |
| Lundbeck LLC | 6 | $190 |
| PFIZER INC. | 12 | $150 |
| EMD Serono, Inc. | 4 | $101 |
| Teva Pharmaceuticals USA, Inc. | 5 | $95 |
| Neurelis, Inc. | 4 | $83 |
| Grifols USA, LLC | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
Products named: QULIPTA, Leqembi, VYEPTI, KISUNLA, AUSTEDO XR, VALTOCO, NURTEC ODT, AMYVID.
Industry payments across MD — which companies pay providers there.
